David Malmstrom, Research

David Malmstrom, JD

Research

Education
George Mason University, School of Law, JD
Florida International University, B.A.

SELECT PUBLICATIONS
“Shackling Innovation: The Regulation of Industry-Supported Clinical Trials,” Competitive Enterprise Institute

“More Regulation of Industry-Supported Biomedical Research: Are We Asking the Right Questions?”, Journal of Law, Medicine, and Ethics

David Malmstrom is an attorney with a decade of complex litigation and high-level qualitative and quantitative research experience focusing on constitutional law, bioethics, class action, and mass tort litigation. He develops and implements the legal and business intelligence platform for Allēus Health Analytics’ mass tort litigation settlement (MDL) and lien subrogation service line that helps healthcare providers, payers, and employers identify optimal avenues to recover uncompensated and undercompensated care costs.

Prior to joining Allēus, David was Head of Research at Garden City Group (GCG), a leading provider of legal administration services in the U.S. and International markets. He led the development and implementation of their business intelligence and business opportunity pipeline. During his tenure at GCG, he worked closely with mass tort clients, assisting with intake and discovery. He also gained valuable complex legal administration experience while working as an integral member of the billion-dollar Deepwater Horizon oil spill case.

David’s litigation experience ranges from researching and identifying suitable test cases at the Institute for Justice, to private practice where he worked in trusts and estates. While clerking at the St. Mary’s County Circuit Court in Maryland he drafted court opinions for civil, criminal, and domestic matters.

David earned his JD from George Mason University School of Law where he was a member of the Journal of Law, Economics, and Policy.  He graduated magna cum laude from Florida International University where he studied International Relations and Economics.